We treat your trial like it’s the only trial that matters. Because for your patients, it is.
World Orphan Drug Congress Europe 2026 | October 27-28, 2026 | Amsterdam, The Netherlands
At World Orphan Drug Congress Europe 2026, meet the Ergomed Clinical Research team to discuss how we help sponsors reduce uncertainty and strengthen execution across rare disease clinical development. From early study strategy and feasibility to patient engagement, site support, and global trial delivery, Ergomed brings the cross-functional expertise needed to turn high-stakes rare disease study plans into trials that move forward with greater confidence.
Speaking Session
“Driven by Insights: Operationalizing Patient-Centric Design in Rare Disease Programs”
Day 1 | 15:10
Meet our Experts
Connect with us at Booth #302 for conversations with biotech and pharmaceutical teams looking for a specialty CRO partner built for complex rare disease studies, vulnerable populations, and high-pressure development decisions.
Built for the realities of rare disease development.
Rare disease development demands more than operational scale. It demands a CRO partner that can simplify complexity without losing sight of the patients, families, sites, and care networks at the center of every study.
Ergomed Clinical Research supports sponsors navigating:
- small and geographically dispersed patient populations
- limited natural history data
- endpoint uncertainty
- complex regulatory and evidence-generation pathways
- caregiver and family burden
- referral pathway challenges
- site readiness and retention risk
- complex logistics across countries, patients, and sites
We work as an extension of your team to help bring greater clarity, stronger coordination, and disciplined delivery to every stage of rare disease clinical development.
Let’s discuss your rare disease development needs!
If you are planning a rare disease study and looking for a CRO partner that understands how to combine strategic insight, patient-centered thinking, and rigorous execution, we would welcome the conversation. Meet Ergomed Clinical Research at Booth #302 during World Orphan Drug Congress Europe 2026 to discuss how we help sponsors make complex rare disease development more executable — from early planning through clinical delivery.
